DOTA (chelator)
| Names | |
|---|---|
| Preferred IUPAC name
2,2′,2′′,2′′′-(1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetic acid | |
| Other names
DotA; Tetraxetan
| |
| Identifiers | |
CAS Number
|
|
3D model (JSmol)
|
|
| ChEBI | |
| ChemSpider | |
| ECHA InfoCard | 100.113.833 |
PubChem CID
|
|
| UNII | |
CompTox Dashboard (EPA)
|
|
InChI
| |
SMILES
| |
| Properties | |
Chemical formula
|
C16H28N4O8 |
| Molar mass | 404.420 g·mol−1 |
| Appearance | White crystalline solid |
| Hazards | |
| GHS labelling: | |
Pictograms
|
|
Signal word
|
Warning |
Hazard statements
|
H315, H319, H335 |
Precautionary statements
|
P261, P305+P351+P338 |
| Related compounds | |
Related compounds
|
Cyclen, EDTA |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
| |
DOTA (also known as tetraxetan) is an organic compound with the formula (CH2CH2NCH2CO2H)4. The molecule consists of a central 12-membered tetraaza (i.e., containing four nitrogen atoms) ring. DOTA is used as a complexing agent, especially for lanthanide ions. Its complexes have medical applications as contrast agents and cancer treatments.